Granules India and NIPER S.A.S Nagar launch Centre of Excellence for Sustainable Pharma Innovation
- Sub Editor
- 34 minutes ago
- 3 min read
New centre to drive green technologies in Drug Product Manufacturing
Granules India Limited, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, today inaugurated the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).
This Granules’ CSR initiative aims to empower students and researchers with access to cutting-edge facilities and resources, fostering innovation in eco-friendly solutions for learning pharmaceutical manufacturing.
This strategic move is in line with the company’s broader vision of integrating sustainability into its core operations. By embedding innovation into green practices, Granules India aims to not only enhance operational efficiency and business resilience but also contribute positively to society and the environment. This initiative reflects the company’s belief that long-term success is deeply rooted in ethical responsibility and environmental stewardship.
Speaking at the inauguration, Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited, said, “At Granules, we believe that innovation and sustainability go hand in hand. Guided by our purpose of Healing Lives Responsibly through Pioneering Green Science, this initiative reflects our commitment to shaping a healthier, more sustainable future, not only for our stakeholders, but also for the communities and ecosystems that sustain us.”
Prof. Dulal Panda, Director, NIPER S.A.S Nagar, added, "This collaboration brings academia and industry together to solve real-world challenges. By focusing on green and sustainable practices, we can deliver solutions that benefit both the environment and patients worldwide."
The Centre, under the supervision of Dr. Arvind. K Bansal, Professor Department of Pharmaceutics, Lead and Academic Supervisor of the Centre will harness NIPER’s academic and research strengths alongside Granules India’s industrial expertise to develop scalable, eco-friendly solutions for the pharmaceutical sector. The collaboration will focus on interface between API and formulation manufacturing, reducing the carbon footprint in formulation production, creating intellectual property in sustainable technologies, training next-generation scientists, and setting new industry benchmarks in sustainable manufacturing.
Together, Granules India and NIPER aim to set a precedent for how industry–academia partnerships can accelerate the transition towards a greener, more responsible future for global healthcare.
About Granules India Ltd. (BSE: 532482, NSE: GRANULES)
Granules India Limited, incorporated in 1991, is a vertically integrated fast-growing Indian pharmaceutical company headquartered in Hyderabad with best-in-class facilities and a commitment to operational excellence, quality, and customer service. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain -- from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL. For more information about Granules India Ltd and its initiatives, please visit www.granulesindia.com
About NIPER, S.A.S Nagar (Mohali)
National Institute of Pharmaceutical Education and Research (NIPER), SAS NAGAR, is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance’. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.
Reach out to us at the PR Desk
Read more on our Partner sites: Dais World | The Progress Catalyst
Get rewarded for your reading habits on the Dais World app!
